Multiple Sclerosis Trial, Recruiting NCT07202195 Sponsor: Daphne Kos Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT07202195
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with multiple sclerosis (MS).
  • You experience ataxia (problems with balance and coordination) or spasticity (muscle stiffness or tightness) that affects the movement of your arms or legs — at least one of these must be confirmed by a specific medical assessment (confirm with trial site).
  • You are able to understand instructions and fill in questionnaires on your own.

Who may not be able to join:

  • You have an implanted medical device inside your body, such as a pacemaker, a pump that delivers medication, a nerve stimulator, a defibrillator, a shunt, or life-support equipment.
  • You have changed your MS medication within the last 3 months.
  • You have received Botulinum Toxin A (sometimes known as Botox, used to treat muscle stiffness) within the last 3 months.
  • You have had an MS relapse (a flare-up of symptoms) within the last 3 months.
  • You have a recent muscle or joint problem that would stop you from completing the physical tests.
  • You are currently pregnant.
  • Your body size is larger than 3XL clothing size.
  • You have a skin rash, wound, swelling, infection, or inflammation on the area of skin where the treatment would be applied.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Daphne Kos, Universitair Ziekenhuis Brussel

Phone: +32496107849

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Daphne Kos
Registry
ClinicalTrials.gov
Start date
1 March 2026
Est. completion
1 September 2027

Where this trial is recruiting

🇧🇪 Belgium 🇩🇰 Denmark

Primary endpoints

NHPT+SSST score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov